Santen Pharmaceutical Co (JP:4536) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Santen Pharmaceutical Co., Ltd. has announced the repurchase of 2,855,300 of its common shares, totaling 4,981,925,500 yen, between July 1 and July 31, 2024. This buyback is part of a larger repurchase program approved by the board on May 9, 2024, which allows for a maximum of 21,110,000 shares to be bought back. To date, the company has repurchased 9,973,000 shares for 16,342,935,400 yen under this program.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.